Bigscreen Beyond: 127 Gram Visor, 2.6K Per Eye OLED VR Headset With SteamVR Tracking

https://uploadvr.com/bigscreen-beyond-weight-specs/

Save GPU with Eye Tracked Foveated Rendering

https://developer.oculus.com/blog/save-gpu-with-eye-tracked-foveated-rendering/

PSVR 2 review: love on a leash

https://www.theverge.com/23601368/sony-playstation-ps-vr2-review-virtual-reality

HairDAO becomes second BioDAO to mint an IP-NFT.

https://twitter.com/HairDAO_/status/1626282930094895107

Apple Delays Debut of AR/VR Headset Until June

https://www.macrumors.com/2023/02/15/apple-ar-vr-headset-launch-june/

Massively Improved Multi-node NVIDIA GPU Scalability with GROMACS

https://developer.nvidia.com/blog/massively-improved-multi-node-nvidia-gpu-scalability-with-gromacs/

Meta Adds Direct Touch Menu Panels To Quest In v50 PTC Update

https://uploadvr.com/meta-direct-touch-menu-quest-ptc/

LocalBitcoins closes down P2P crypto exchange service

https://cointelegraph.com/news/localbitcoins-closes-down-the-p2p-crypto-exchange-service

Crypto bank Silvergate ranks as the second most-shorted stock on Wall Street

https://cointelegraph.com/news/crypto-bank-silvergate-ranks-as-the-second-most-shorted-stock-on-wall-street

Large language models generate functional protein sequences across diverse families

https://twitter.com/jermdemo/status/1619214824185147392?s=46&t=BnRBgAZ-NwFelhA49dKknw

Pfizer Invests $4.1 Million In Decentralized Science Organization VitaDAO Fundraising Round

https://thedalesreport.com/trends/pfizer-invests-4-1-million-in-decentralized-science-organization-vitadao-fundraising-round/

Prisms VR raises $12.5M to improve math literacy with virtual reality

https://venturebeat.com/games/prisms-vr-raises-12-5m-to-improve-math-literacy-with-virtual-reality/

Meta is inexplicably shutting down one of the best Oculus games

https://www.theverge.com/2023/1/31/23580356/meta-shut-down-echo-vr-oculus-quest-arena-ready-at-down

Rumor: HP will finish VR related production by the end of the year

https://twitter.com/SadlyItsBradley/status/1620729001152237569?s=20&t=4LKuZnzOtX9tXp4LfGoETQ

https://uploadvr.com/microsoft-kills-altspace/ 

https://www.windowscentral.com/microsoft/microsoft-has-laid-off-entire-teams-behind-virtual-mixed-reality-and-hololens

https://www.roadtovr.com/report-apple-mixed-reality-headset-specs/ 

https://www.playstation.com/en-us/ps-vr2/ 

https://uploadvr.com/meta-quest-pro-price-drop/

https://jcheminf.biomedcentral.com/articles/10.1186/s13321-022-00664-x

• https://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trials
• https://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/
• https://twitter.com/PDBeurope/status/1613121823452839936
• https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipo

Special thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events! 

https://www.roadtovr.com/htc-vive-xr-elite-price-release-quest-pro-competitor-1100/

https://uploadvr.com/shiftalls-meganex-price-shipping/

https://uploadvr.com/windows-mr-grows-reverb-g2-sales/

https://uploadvr.com/razer-meta-quest-2-vr-accessories/

https://www.forbes.com/sites/johncumbers/2023/01/05/drug-manufacture-has-one-huge-flaw-this-synthetic-biology-startup-just-raised-200m-to-fix-it/?sh=635c8caf89ed

https://www.axios.com/2023/01/04/celsius-bankruptcy-earn-accounts

In this episode, we recap the Top Science Metaverse stories of 2022, and make bold predictions for what's to come for the science Metaverse in 2023

Tune in to see Application Scientists from Nanome discuss how drug design and discovery can be improved across teams using XR. From pocket characterization to docking, and more, teams from all over the world can still come together in the space through the power of XR tools

Keita Funakawa
COO
Nanome

Keita Funakawa is Nanome's COO. Keita’s passion lies at the intersection of emerging technologies, digital arts, and science. He graduated from UC San Diego with a B.S. in Management Science (Quantitative Economics) and a minor in Visual Arts Digital Media. He co-founded Nanome in 2015 and now leads company operations.

Mike Bishop
Drug Discovery Consultant
Nanome

Mike Bishop started Bishop Drug Discovery Consulting in 2019 after 26 years as a medicinal chemist with GSK. From 2001 to 2014 he directed a department of medicinal chemists and DMPK scientists with a focus on metabolic diseases, identifying ~10 clinical development candidates. From 2014 to 2019, Mike served as a Director in GSK’s Discovery Partnerships with Academia (DPAc) unit, with responsibilities for thorough vetting of research opportunities across multiple therapeutic areas, building collaborative workplans and leading joint research programs with academic investigators. Mike earned a B.A. in chemistry from Rice University in Houston, TX, worked in the petrochemical industry with Amoco Chemical in Texas City, TX for two years, and then returned to Rice, earning a Ph.D. in organic chemistry under the guidance of Dr. Marco Ciufolini.

Jonathon Gast
Senior Application Scientist
Nanome

Jonathon Gast has a background in pharmacology, informatics, and medicinal chemistry. He completed his Ph.D. in molecular pharmacology at Purdue University with a focus on the creation of informatic approaches for the determination of mechanisms of action of synthetic lethal combinations. As an applications scientist at Nanome, he communicates with customers to understand their research objectives to create novel solutions through Nanome. This includes the creation of customized software, on-site training, or online demonstrations.